102
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Altered Apoptosis Pathways in Mantle Cell Lymphoma

, , , &
Pages 49-54 | Received 15 May 2003, Published online: 03 Aug 2009

References

  • Argatoff, L.H., Connors, J.M., Klasa, R.J., Horsman, D.E. and Gascoyne, R.D. (1997) "Mantle cell lymphoma: a clinicopathologic study of 80 cases", Blood, 89, 2067–2078.
  • Bosch, F., Lopez-Guillermo, A., Campo, E., et al. (1998) "Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors", Cancer, 82, 567–575.
  • Weisenburger, D.D., Vose, J.M., Greiner, T.C., et al. (2000) "Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska lymphoma study group", American Journal of Hematology, 64, 190— 196.
  • Meusers, P., Hense, J. and Brittinger, G. (1997) "Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems", Leukemia, 11\(Suppl 2), S60–64.
  • Coiffier, B. (1998) "Which treatment for mantle-cell lymphoma patients in I998?" Journal of Clinical Oncology, 16, 3–5.
  • Freedman, A.S., Neuberg, D., Gribben, J.G., et al. (1998) "High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission", Journal of Clinical Oncology, 16, 13 — 18.
  • Armitage, J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project", Journal of Clinical Oncology, 16, 2780–2795.
  • Kilo, M.N. and Dorfman, D.M. (1996) "The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma", American Journal of Clinical Pathology, 105, 451 — 457.
  • Dunphy, C.H., Wheaton, S.E. and Perkins, S.L. (1997) "CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma", Modern Pathology, 10, 818–822.
  • Yatabe, Y., Suzuki, R., Tobinai, K., et al. (2000) "Significance of cyclin DI overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin DI-positive MCL and cyclin DI-negative MCL-like B-cell lymphoma", Blood, 95, 2253 — 2261.
  • Frater, J.L. and Hsi, E.D. (2002) "Properties of the mantle cell and mantle cell lymphoma", Current Opinion in Hematology, 9, 56–62.
  • Pascual, V., Liu, Y.J. and Banchereau, J. (1997) "Normal human B cell subpopulations and their malignant counterparts", Baillieres Clinical Haematology, 10, 525–538.
  • Rimokh, R., Berger, F., Delsol, G., et al. (1994) "Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas", Blood, 83, 1871–1875.
  • Li, J.Y., Gaillard, F., Moreau, A., et al. (1999) "Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization", American Journal of Pathology, 154, 1449 — 1452.
  • Stokke, T., DeAngelis, P., Smedshammer, L., et al. (2001) "Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lympho-ma", British Journal of Cancer, 85, 1900–1913.
  • Bentz, M., Plesch, A., Bullinger, L., et al. (2000) "t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia", Genes Chromosomes Cancer, 27, 285–294.
  • Levy, V., Ugo, V., Delmer, A., et al. (1999) "Cyclin DI over-expression allows identification of an aggressive subset of leukemic lymphoproliferative disorder", Leukemia, 13, 1343–1351.
  • Vasef, M.A., Medeiros, L.J., Koo, C., McCourty, A. and Brynes, R.K. (1997) "Cyclin DI immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow", American Journal of Clinical Pathology, 108, 302–307.
  • Swerdlow, S.H., Yang, W.I., Zukerberg, L.R., Harris, N.L., Arnold, A. and Williams, M.E. (1995) "Expression of cyclin DI protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin DI gene", Human Pathology, 26, 999–1004.
  • Bosch, F., Jares, P., Campo, E., et al. (1994) "PRAD-1/cyclin DI gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma", Blood, 84, 2726 — 2732.
  • Lovec, H., Grzeschiczek, A., Kowalski, M.B. and Moroy, T. (1994) "Cyclin D1/bc1-1 cooperates with myc genes in the generation of B-een lymphoma in transgenic mice", EMBO Journal, 13, 3487 — 3495.
  • Bodrug, SE., Warner, B.J., Bath, M.L., Lindeman, G.J., Harris, A.W. and Adams, J.M. (1994) "Cyclin DI transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene", EMBO Journal, 13, 2124–2130.
  • Ott, M.M., Bartkova, J., Bartek, J., et al. (1997) "Cyclin DI expression in mantle cell lymphoma is accompanied by down-regulation of cyclin D3 and is not related to the proliferative activity", Blood, 90, 3154— 3159.
  • Hermann, M., Scholman, H.J., Marafioti, T., Stein, H. and Schriever, F. (1997) "Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues", European Journal of Haematology, 59, 20— 30.
  • Ott, MM., Ott, G., Kuse, R., et al. (1994) "The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices", Histopathology, 24, 329–334.
  • Ott, G., Kalla, J., Hanke, A., et al. (1998) "The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features", Leukemia and Lymphoma, 32, 55–63.
  • Raty, R., Franssila, K., Joensuu, H., Teerenhovi, L. and Elonen, E. (2002) "Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma", European Journal of Haematology, 69, II— 20.
  • Majlis, A., Pugh, W.C., Rodriguez, MA., Benedict, W.F. and Cabanillas, F. (1997) "Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants", Journal of Clinical Oncology, 15, 1664 — 1671.
  • Zoldan, MC., Inghirami, G., Masuda, Y., et al. (1996) "Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome", British Journal of Haema-tology, 93, 475–486.
  • Raty, R., Franssila, K., Jansson, SE., Joensuu, H., Wartiovaara-Kautto, U. and Elonen, E. (2003) "Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma", European Journal of Cancer, 39, 321–329.
  • Ratech, H. (1995) "Molecular pathology of low grade malignant lymphomas", Medical Oncology, 12, 167— 176.
  • Agarwal, B. and Naresh, K.N. (2002) "Bc1-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases", American Journal of Hematology, 70, 278–282.
  • Korz, C., Pscherer, A., Benner, A., et al. (2002) "Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes", Blood, 99, 4554–4561.
  • Xerri, L., Devilard, E., Bouabdallah, R., et al. (1999) "Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas", Leukemia, 13, 1548–1553.
  • Clodi, K., Snell, V., Zhao, S., Cabanillas, F., Andreeff, M. and Younes, A. (1998) "Unbalanced expression of Fas and CD40 in mantle cell lymphoma", British Journal of Haematology, 103, 217–219.
  • Hermann, M., Niemitz, C., Marafioti, T. and Schriever, F. (1998) "Reduced phagocytosis of apoptotic cells in malignant lymphoma", International Journal of Cancer, 75, 675 —679.
  • de Vos, S., Krug, U., Hofmann, W.K., et al. (2003) "Cell Cycle Alterations in the Blastoid Variant of Mantle Cell Lymphoma (MCL-BV) as Detected by Gene Expression Profiling of Mantle Cell Lymphoma (MCL) and MCL-BV", Diagnostic Molecular Pathol-ogy, 12, 35–43.
  • Rosenwald, A., Wright, G., Wiestner, A., et al. (2003) "The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma", Cancer Cell, 3, 185–197.
  • Hofmann, W.K., de Vos, S., Tsukasalci, K., et al. (2001) "Altered apoptosis pathways in mantle cell lymphoma detected by oligonu-cleotide microarray", Blood, 98, 787–794.
  • Chang, H.Y., Yang, X. and Baltimore, D. (1999) "Dissecting Fas signaling with an altered-specificity death-domain mutant: require-ment of FADD binding for apoptosis but not Jun N- terminal lcinase activation", Proceedings of the National Academy of Sciences of the United States of America, 96, 1252— 1256.
  • Djerbi, M., Screpanti, V., Catrina, AT., Bogen, B., Biberfeld, P. and Grandien, A. (1999) "The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors", Journal of Experimental Medicine, 190, 1025 — 1032.
  • Yang, X., Khosravi-Far, R., Chang, H.Y. and Baltimore, D. (1997) "Daxx, a novel Fas-binding protein that activates JNK and apoptosis", Cell, 89, 1067 — 1076.
  • Toni, S., Egan, D.A., Evans, R.A. and Reed, J.C. (1999) "Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)", EMBO Journal, 18, 6037–6049.
  • Ek, S., Hogerkorp, C.M., Dictor, M., Ehinger, M. and Borrebaeck, C.A. (2002) "Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells", Cancer Research, 62, 4398 —4405.
  • Stilgenbauer, S., Schaffner, C., Winkler, D., et al. (2000) "The ATM gene in the pathogenesis of mantle-cell lymphoma", Annals of Oncology, 11\(Suppl 1), 127–130.
  • Wellmann, A., Thieblemont, C., Pittaluga, S., et al. (2000) "Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas", Blood, 96, 398–404.
  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, 503 — 511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.